Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Deborah Collyar: What's In It for Patients?

Advertisement

Advertisement




Apr
09
Today In Oncology
How Cannabis Use May Be Accelerating Breast and Testicular Cancer Rates in AYAs
Japanese Study Looks at Rates of Cancer Therapy–Related AML
Researchers Identify Blood-Based Biomarker for Cancer Risk in People With Lynch Syndrome
Final Report on Pralsetinib in Advanced RET Fusion–Positive NSCLC
New ASH HematOmics Program Offers Blood Cancer Data Integration Tool to Accelerate Research
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo